- $6.65bn
- $6.82bn
- $8.74bn
- 71
- 76
- 88
- 93
Annual income statement for Nov, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | PRESS |
| Standards: | USG | USG | USG | USG | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 5,524 | 7,237 | 8,583 | 8,870 | 8,744 |
| Cost of Revenue | |||||
| Gross Profit | 774 | 1,334 | 1,833 | 2,010 | 1,767 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 5,658 | 6,973 | 7,932 | 7,994 | 8,250 |
| Operating Profit | -134 | 264 | 651 | 876 | 494 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -230 | 238 | 612 | 831 | 375 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -245 | 155 | 985 | 635 | 151 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -250 | 155 | 993 | 635 | 145 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -250 | 155 | 993 | 635 | 145 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.636 | 0.64 | 2.53 | 1.39 | 0.461 |
| Dividends per Share | |||||
| Special Dividends per Share |